Therapeutic Advances in Respiratory Disease

Scope & Guideline

Elevating Standards in Pulmonary Research

Introduction

Explore the comprehensive scope of Therapeutic Advances in Respiratory Disease through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Therapeutic Advances in Respiratory Disease in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1753-4658
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationTHER ADV RESPIR DIS / Ther. Adv. Respir. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Respiratory Disease' primarily focuses on advancing knowledge and therapeutic strategies related to respiratory diseases. It encompasses a broad range of studies aimed at improving patient outcomes through innovative research and clinical practice. The journal emphasizes the integration of clinical findings, therapeutic advancements, and patient-reported outcomes in the field of respiratory health.
  1. Clinical Research in Respiratory Diseases:
    The journal publishes original research on various respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and infections, emphasizing clinical trials and observational studies.
  2. Innovative Therapeutic Approaches:
    It highlights studies on novel therapeutic interventions, including pharmacological treatments, biologics, and advanced medical technologies such as robotic-assisted bronchoscopy and endobronchial ultrasound.
  3. Diagnostic Advances:
    Research focusing on novel diagnostic methods and biomarkers for respiratory diseases is a key area, including studies on imaging techniques, molecular diagnostics, and the validation of clinical assessment tools.
  4. Patient-Centered Outcomes:
    The journal places a strong emphasis on patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with respiratory diseases, aiming to incorporate patient perspectives into clinical practice.
  5. Epidemiology and Public Health:
    It includes epidemiological studies that analyze the prevalence, risk factors, and burden of respiratory diseases in various populations, providing insights into public health implications.
Recent publications in 'Therapeutic Advances in Respiratory Disease' reflect emerging trends and themes that are gaining traction. These areas indicate the journal's responsiveness to current challenges and advancements in respiratory medicine.
  1. Personalized Medicine and Biomarkers:
    There is a growing focus on personalized treatment strategies and the identification of biomarkers that guide therapy, particularly in complex diseases like asthma and COPD, highlighting the importance of individualized patient care.
  2. Impact of COVID-19 on Respiratory Health:
    Research examining the long-term effects of COVID-19 on respiratory health, including post-acute sequelae and rehabilitation strategies, has seen a significant rise, reflecting an urgent need for addressing the pandemic's implications.
  3. Interventional Pulmonology Techniques:
    Emerging interest in advanced interventional techniques such as endobronchial ultrasound and robotic bronchoscopy is evident, showcasing the journal's commitment to reporting on innovative procedures that enhance diagnostic and therapeutic capabilities.
  4. Telemedicine and Digital Health Solutions:
    The incorporation of telemedicine and digital health solutions into respiratory disease management is trending, with studies focusing on their effectiveness in improving access to care and patient outcomes during and after the COVID-19 pandemic.
  5. Multidisciplinary Approaches to Treatment:
    There is an increasing emphasis on multidisciplinary care models that integrate various specialties to address the complex needs of patients with respiratory diseases, reflecting a holistic approach to treatment.

Declining or Waning

As the field evolves, certain themes within 'Therapeutic Advances in Respiratory Disease' appear to be losing prominence. This decline may reflect shifting research priorities or advancements in understanding that have made some previously emphasized topics less critical or relevant.
  1. Traditional Therapeutic Approaches:
    There is a noticeable decrease in research focusing solely on traditional pharmacological therapies, such as older inhalers and medications, as more emphasis is placed on novel therapies and personalized medicine.
  2. Basic Science Research:
    The journal has seen a reduction in the publication of purely basic science studies that do not directly translate to clinical application, indicating a shift towards more clinically relevant research.
  3. Single-Disease Focus Studies:
    Research dedicated to single diseases without interdisciplinary approaches is waning, as the journal increasingly emphasizes studies that consider comorbid conditions and multifactorial influences on respiratory health.

Similar Journals

Annals of Thoracic Medicine

Fostering collaboration in the pursuit of thoracic excellence.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1817-1737Frequency: 4 issues/year

Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.

Minerva Respiratory Medicine

Connecting research and practice in pulmonary health.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Lung India

Advancing respiratory health through accessible research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Unveiling breakthroughs in respiratory and critical care.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

RESPIRATORY MEDICINE

Pioneering Research for Better Breathing
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Annals of the American Thoracic Society

Shaping the future of respiratory medicine with cutting-edge insights.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Multidisciplinary Respiratory Medicine

Exploring innovative insights in multidisciplinary respiratory care.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Pulmonology

Exploring the frontiers of respiratory health and innovation.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Zeitschrift fur Pneumologie

Empowering Knowledge for Better Respiratory Care
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

Lancet Respiratory Medicine

Innovating treatment strategies for respiratory diseases.
Publisher: ELSEVIER SCI LTDISSN: 2213-2600Frequency: 12 issues/year

The Lancet Respiratory Medicine, published by Elsevier in the United Kingdom, is a premier journal dedicated to the field of pulmonary and respiratory medicine. With its impressive impact factor and a prestigious ranking of #1 out of 155 in its category as of 2023, it holds a remarkable position in advancing research and clinical practices in respiratory health. The journal invites original research, reviews, and clinical studies that aim to propel the understanding of respiratory diseases, fostering innovations in treatment and management strategies. Operating under a Q1 category in Scopus rankings, it is an essential platform for researchers, healthcare professionals, and students who are committed to enhancing patient care and advancing knowledge in this crucial area of medicine. The Lancet Respiratory Medicine remains a vital resource for the latest findings and discussions shaping the future of respiratory health.